Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07220447 · ClinicalTrials.gov registry record · Early Phase 1

L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance

A Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, sponsored by City of Hope Medical Center.

Recruiting
Registry status
Early Phase 1
Development phase
50
Enrollment target
4
Study locations

NCT07220447 is a Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 50 participants, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (96% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07220447, a Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, is actively recruiting participants, sponsored by City of Hope Medical Center.

RECRUITING
Registry status
Early Phase 1
Development phase
50 participants
Enrollment target
4
Study locations

Study Summary

This clinical trial tests the feasibility, best dose, and effectiveness of L-theanine for supporting relaxation and mood among cancer patients in surveillance. L-theanine is a substance found in the leaves of green tea with potential to enhance mental health and well-being. It works by increasing certain chemicals within the body that have been associated with stress reduction, mood stabilization, and improved cognitive performance.

Conditions Studied

Malignant Solid Neoplasm Hematopoietic and Lymphatic System Neoplasm

Interventions

  • OTHER Survey Administration
  • DRUG Theanine

Study Locations (4)

California

  • City of Hope Medical Center - Duarte
  • City of Hope Seacliff - Huntington Beach
  • City of Hope at Irvine Lennar - Irvine
  • City of Hope at Irvine Sand Canyon - Irvine

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-04-01
Est. Completion 2027-07-09
Phase Early Phase 1

Sponsor

City of Hope Medical Center

582 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07220447

The ClinicalTrials.gov registry entry for NCT07220447 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (96% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Survey Administration is the first listed.

NCT07220447 reports 4 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07220447 about?

NCT07220447 is a clinical study titled "L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance". This clinical trial tests the feasibility, best dose, and effectiveness of L-theanine for supporting relaxation and mood among cancer patients in surveillance. L-theanine is a substance found in the leaves of green tea with potential to enhance mental health and well-being. It works by increasing ce...

What is the current status of trial NCT07220447?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2026-04-01. Estimated completion is 2027-07-09.

What conditions does trial NCT07220447 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm.

What interventions are being tested in trial NCT07220447?

The interventions under investigation include: Survey Administration (OTHER), Theanine (DRUG).

Who is sponsoring clinical trial NCT07220447?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07220447 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Malignant Solid Neoplasm

All registered trials for this condition

Hematopoietic and Lymphatic System Neoplasm

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.